Figure 2.
GADA titers in subgroups of patients with various diabetes-specific autoantibody patterns. GADA-only autoantibodies were present in 91 patients, ZnT8+GADA in 31 patients, IA-2+GADA in 17 patients, and ZnT8+IA-2+GADA in 50 patients. The results are medians/IQR (Kruskal–Wallis ANOVA followed by Dunn’s post-hoc test). GADA: glutamic acid decarboxylase antibodies; ZnT8: zinc transporter-8; IA-2: anti-islet-2 antibodies.
